申请人:Imperial Chemical Industries PLC
公开号:US05283245A1
公开(公告)日:1994-02-01
The invention concerns a thiazole of the formula I, ##STR1## wherein Q.sup.1 is an optionally substituted 6-membered monocyclic or 10-membered bicyclic heterocyclic moiety containing one or two nitrogen atoms; X is oxy, thio, sulphinyl, sulphonyl or imino; Ar is phenylene which may optionally bear one or two substituents, or Ar is an optionally substituted 6-membered heterocyclene moiety contining up to three nitrogen atoms; R.sup.1 is hydrogen, (1-6C)alkyl, (2-6C)alkenyl, (2-6C)alkynyl or substituted (1-4C)alkyl; R.sup.2 is hydrogen, (1-6C)alkyl, (3-6C)alkenyl, (3-6C)alkynyl or substituted (1-4C)alkyl or R.sup.2 is optionally substituted benzoyl; and Q.sup.2 is optionally substituted thiazolyl; or a pharmaceutically-acceptable salt thereof. The invention also concerns processes for the manufacture of a thiazole of the formula I and pharmaceutical compositions containing said thiazole.
该发明涉及一种公式I的噻唑,其中Q1是一个含有一个或两个氮原子的可选取代的6元单环或10元双环杂环基团;X是氧、硫、亚磺酰基、磺酰基或亚胺基;Ar是苯基,可以选择性地带有一个或两个取代基,或者Ar是一个可选取代的6元杂环基团,其中含有最多三个氮原子;R1是氢、(1-6C)烷基、(2-6C)烯基、(2-6C)炔基或取代的(1-4C)烷基;R2是氢、(1-6C)烷基、(3-6C)烯基、(3-6C)炔基或取代的(1-4C)烷基,或者R2是可选取代的苯甲酰基;Q2是可选取代的噻唑基;或其药学上可接受的盐。该发明还涉及一种制造公式I噻唑的方法和含有该噻唑的药物组合物。